These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24326321)

  • 21. Increased risk of glomerular hyperfiltration in subjects with impaired glucose tolerance and newly diagnosed diabetes.
    Sun ZJ; Yang YC; Wu JS; Wang MC; Chang CJ; Lu FH
    Nephrol Dial Transplant; 2016 Aug; 31(8):1295-301. PubMed ID: 26610595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A1C cut points to define various glucose intolerance groups in Asian Indians.
    Mohan V; Vijayachandrika V; Gokulakrishnan K; Anjana RM; Ganesan A; Weber MB; Narayan KM
    Diabetes Care; 2010 Mar; 33(3):515-9. PubMed ID: 19903752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of impaired fasting glucose and impaired glucose tolerance on arterial stiffness in an older Chinese population: the Guangzhou Biobank Cohort Study-CVD.
    Xu L; Jiang CQ; Lam TH; Cheng KK; Yue XJ; Lin JM; Zhang WS; Thomas GN
    Metabolism; 2010 Mar; 59(3):367-72. PubMed ID: 19828159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular characteristics in subjects with increasing levels of abnormal glucose regulation: the Strong Heart Study.
    Capaldo B; Di Bonito P; Iaccarino M; Roman MJ; Lee ET; Devereux RB; Riccardi G; Howard BV; de Simone G
    Diabetes Care; 2013 Apr; 36(4):992-7. PubMed ID: 23223343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study.
    Li Y; Feng D; Esangbedo IC; Zhao Y; Han L; Zhu Y; Fu J; Li G; Wang D; Wang Y; Li M; Gao S; Willi SM
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of type 2 diabetes mellitus according to 2-h plasma glucose level: The Korean Genome and Epidemiology Study (KoGES).
    Park SK; Ryoo JH; Oh CM; Choi JM; Choi YJ; Lee KO; Jung JY
    Diabetes Res Clin Pract; 2018 Dec; 146():130-137. PubMed ID: 28951335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin sensitivity and secretion in Arab Americans with glucose intolerance.
    Salinitri FD; Pinelli NR; Martin ET; Jaber LA
    Diabetes Technol Ther; 2013 Dec; 15(12):1019-24. PubMed ID: 23919587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance.
    Abdul-Ghani MA; Matsuda M; Jani R; Jenkinson CP; Coletta DK; Kaku K; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E401-6. PubMed ID: 18492770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients.
    Sciacqua A; Miceli S; Carullo G; Greco L; Succurro E; Arturi F; Sesti G; Perticone F
    Diabetes Care; 2011 Jun; 34(6):1406-11. PubMed ID: 21515837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction in Global Myocardial Glucose Metabolism in Subjects With 1-Hour Postload Hyperglycemia and Impaired Glucose Tolerance.
    Succurro E; Pedace E; Andreozzi F; Papa A; Vizza P; Fiorentino TV; Perticone F; Veltri P; Cascini GL; Sesti G
    Diabetes Care; 2020 Mar; 43(3):669-676. PubMed ID: 31974102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes.
    Chou P; Li CL; Wu GS; Tsai ST
    Diabetes Care; 1998 Jul; 21(7):1183-7. PubMed ID: 9653617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile.
    Sesti G; Fiorentino TV; Succurro E; Perticone M; Arturi F; Sciacqua A; Perticone F
    Acta Diabetol; 2014 Dec; 51(6):927-32. PubMed ID: 24619654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
    Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
    Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans.
    Wang Z; Zhang H; Shen XH; Jin KL; Ye GF; Qiu W; Qian L; Li B; Zhang YH; Shi GP
    Ann Med; 2013 May; 45(3):220-9. PubMed ID: 23110545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukocyte telomere length is inversely associated with post-load but not with fasting plasma glucose levels.
    Khalangot M; Krasnienkov D; Vaiserman A; Avilov I; Kovtun V; Okhrimenko N; Koliada A; Kravchenko V
    Exp Biol Med (Maywood); 2017 Apr; 242(7):700-708. PubMed ID: 28299976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The change in one-hour postload plasma glucose levels, and an analysis of its related factors in abdominally obese Han Chinese men with normal glucose tolerance.
    Qin CM; Wang R; Yin FZ; Liu B; Ma CM; Lu Q
    J Diabetes Complications; 2012; 26(6):536-9. PubMed ID: 22739800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
    Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
    Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
    Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.